Cargando…

CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein

The adaptive immune response to severe acute respiratory coronavirus 2 (SARS-CoV-2) is important for vaccine development and in the recovery from coronavirus disease 2019 (COVID-19). Men and cancer patients have been reported to be at higher risks of contracting the virus and developing the more sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taborska, Pavla, Strizova, Zuzana, Stakheev, Dmitry, Sojka, Ludek, Bartunkova, Jirina, Smrz, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128251/ https://www.ncbi.nlm.nih.gov/pubmed/34012431 http://dx.doi.org/10.3389/fimmu.2021.629102

Ejemplares similares

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
por: Taborska, Pavla, et al.
Publicado: (2021)

Acute Conditioning of Antigen-Expanded CD8(+) T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge
por: Taborska, Pavla, et al.
Publicado: (2020)

The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro
por: Stakheev, Dmitry, et al.
Publicado: (2019)

Thapsigargin-Stimulated LAD2 Human Mast Cell Line Is a Potent Cellular Adjuvant for the Maturation of Monocyte-Derived Dendritic Cells for Adoptive Cellular Immunotherapy
por: Taborska, Pavla, et al.
Publicado: (2021)

LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy
por: Stakheev, Dmitry, et al.
Publicado: (2022)

Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors
por: Kalkusova, Katerina, et al.
Publicado: (2022)

Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy
por: Podrazil, Michal, et al.
Publicado: (2022)

Tumoral and paratumoral NK cells and CD8(+) T cells of esophageal carcinoma patients express high levels of CD47
por: Strizova, Zuzana, et al.
Publicado: (2020)

The Role of miR-155 in Antitumor Immunity
por: Kalkusova, Katerina, et al.
Publicado: (2022)

The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor—Immune System Interplay
por: Kuchar, Martin, et al.
Publicado: (2021)

The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials
por: Snajdauf, Martin, et al.
Publicado: (2021)

Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response
por: Strizova, Zuzana, et al.
Publicado: (2021)

Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective?
por: Ozaniak, Andrej, et al.
Publicado: (2021)

The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy
por: Votava, Michal, et al.
Publicado: (2022)

Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy
por: Taborska, Pavla, et al.
Publicado: (2023)

Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients
por: Hensler, Michal, et al.
Publicado: (2015)

The Immune Contexture of Liposarcoma and Its Clinical Implications
por: Resag, Antonia, et al.
Publicado: (2022)

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
por: Walls, Alexandra C., et al.
Publicado: (2020)

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
por: Walls, Alexandra C., et al.
Publicado: (2020)

Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies
por: Milota, Tomas, et al.
Publicado: (2023)

The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
por: Souza, Pedro F.N., et al.
Publicado: (2022)

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
por: Duan, Liangwei, et al.
Publicado: (2020)

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
por: Fucikova, Jitka, et al.
Publicado: (2019)

The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
por: Knierman, Michael D., et al.
Publicado: (2020)

Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus
por: Godet, Murielle, et al.
Publicado: (1991)

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines
por: Kloudová, Kamila, et al.
Publicado: (2016)

Anti-domain 1 β2 glycoprotein antibodies increase expression of tissue factor on monocytes and activate NK Cells and CD8+ cells in vitro
por: Manukyan, Gayane, et al.
Publicado: (2020)

Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 spike glycoprotein
por: Stamatakis, George, et al.
Publicado: (2021)

Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein
por: Tortorici, M. Alejandra, et al.
Publicado: (2022)

Orthobunyavirus Ultrastructure and the Curious Tripodal Glycoprotein Spike
por: Bowden, Thomas A., et al.
Publicado: (2013)

Incorporation of Spike and Membrane Glycoproteins into Coronavirus Virions
por: Ujike, Makoto, et al.
Publicado: (2015)

Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
por: Wang, Lin, et al.
Publicado: (2020)

Proteolysis of Sars-Associated Coronavirus Spike Glycoprotein
por: Simmons, Graham, et al.
Publicado: (2006)

Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
por: Ragotte, Robert J., et al.
Publicado: (2021)

Exploration of antigenic determinants in spike glycoprotein of SARS-CoV2 and identification of five salient potential epitopes
por: Agrawal, Aditya, et al.
Publicado: (2021)

Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs
por: Slabáková, Eva, et al.
Publicado: (2021)

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
por: Podrazil, Michal, et al.
Publicado: (2015)

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines
por: Hensler, Michal, et al.
Publicado: (2022)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Comparison of bovine coronavirus (BCV) antigens: Monoclonal antibodies to the spike glycoprotein distinguish between vaccine and wild-type strains
por: Hussain, Khalid A., et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_4cv8mml9tui5alh507saqsej1h